Pressure BioSciences, Inc.

In September 2004, the majority of the assets and liabilities of the Company were sold to SeraCare Life Sciences; immediately thereafter, the Company changed its name to Pressure BioSciences, Inc. went public on October 31, 1996 under its former name Boston Biomedica, Inc. Schumacher, the founder of our Company, has served as a director of Pressure BioSciences since the formation of its legacy bus

iness, Boston Biomedica, Inc., in 1978. He has served as CEO of Pressure BioSciences since April 2004 and President since September, 2004. He previously served as CEO and Chairman of the Board of Boston Biomedica from 1992 to February, 2003 and as President from 1986 to August 1999. Schumacher served as the Director of Infectious Disease Services for Clinical Sciences Laboratory, a New England-based medical reference laboratory, from 1986 to 1988. From 1972 to 1985, Mr. Schumacher was employed by the Center for Blood Research, a nonprofit medical research institute associated with Harvard Medical School. Schumacher received a BS in Zoology from the University of New Hampshire.